[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Congrats to Sarah Boyce & Avidity Biosciences ($RNA) team on $12B Novartis ($NVS) deal Some other 2025 #BiotechCEOSisterhood deals: Sharon Mates ($ITCI $JNJ) $14.6B @KateHaviland ($BPMC $SNY) $9.5B HeatherTurner_ (Carmot $RHHBY) $2.7B @lshawverO (Capstan $ABBV) $2.1B Sophie Kornowski (Boston Pharma $GSK) $2.1B Ivana Magovevi-Liebisch ($VIGL $SNY) $470M Jill Milne ($ATXS $BCRX) $400M Zhen Li (ADARx $ABBV) $335M @CMillerPharma (Melinta $CRMD) $300M+ $XBI $IBB"
X Link @daphnezohar 2025-10-26T19:10Z 25.5K followers, 11.8K engagements
"Seems like clock should start for $SNY to bid on $VTYX now. For the equiv $VIGL $SNY set up $VIGL delivered data to $SNY 1mo after public disclosure SNY expressed interest on 3/17 and offered to buy company on 4/2. Clock is a ticking"
X Link @unicornbiotech 2025-10-23T17:27Z XXX followers, XXX engagements
"Will be mobile till Nov 5th. less active but check from mobile time to time GL and wish you all the best"
X Link @Maximus_Holla 2025-10-22T21:39Z 54.1K followers, 14.2K engagements
"Remember $PRVB and $VIGL both had partnerships with $SNY then got bought $PRVB Provention received a $XX million non-refundable payment from Sanofi up-front in exchange for granting Sanofi a one-time right of first negotiation (ROFN) to obtain exclusive global rights to commercialize Teplizumab in T1D then bought out $VIGL: In June 2024 Sanofi invested US $XX million in Vigil which included exclusive first-negotiation rights to Vigils oral TREM2 agonist program (VG-3927) then bought out $VTYX in Sep 2024 $SNY Sanofi made a $XX million equity investment in Ventyx by purchasing 70601 Series A"
X Link @Maximus_Holla 2025-10-22T21:26Z 54.1K followers, 35.9K engagements